Stryker (NYSE:SYK) said today that it acquired HyperBranch Medical Technology and its Adherus AutoSpray dural sealant for $220 million. Durham, N.C.-based HyperBranch won pre-market approval from the FDA for the Adherus Autospray sealant in March 2015 and is one of two such sealants allowed on the U.S. market. The other, DuraSeal, won an FDA nod for Covidien in 2011; Covidien dealt […]
HyperBranch Medical Technologies
Integra LifeSciences (NSDQ:IART) yesterday hit rival HyperBranch Medical Technology with a lawsuit alleging infringement of 6 patents related to the DuraSeal neurosurgical sealant it acquired along with Confluent Surgical last year. Covidien dealt its Confluent Surgical line to Integra in January 2014 for $235 million in up-front cash and another $30 million in milestones. Yesterday Integra said Durham, […]
Stratatech Corp. won a $4.6 million grant to run a clinical trial from the National Institute of Diabetes & Digestive & Kidney Diseases.
The funds will support the first human study of Stratatech’s ExpressGraft Antimicrobial genetically engineered living skin substitute as a therapy for diabetic foot ulcers.